Parallax Volatility Advisers, L.P. Aerie Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $3.48 Million - $4.58 Million	-61,946 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $2.96 Million - $4.36 Million	61,946 New	61,946 $4.18 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $257,796 - $307,440	-5,040 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $256,284 - $328,104	5,040	5,040 $301,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.